Added to YB: 2025-02-17
Pitch date: 2025-02-13
BEAT [bullish]
HeartBeam, Inc.
+3.6%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting.
Market Cap
$66.8M
Pitch Price
$2.22
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.24
P/E
-2.71
EV/Sales
N/A
Sector
Health Care Equipment and Supplies
Category
growth
Heartbeam Update: Device FDA Approved and Financing Completed
BEAT: First FDA clearance for cable-free, credit card-sized 12-lead ECG device. Clinical studies show 28% improvement in atrial flutter detection vs single-lead ECGs. 510(k) submitted for ECG synthesis software. $250M-$2.6B+ annual revenue potential across multiple markets. $5.8M cash, no debt. Commercialization expected Q3/Q4 2025. 17 patents protect IP.
Read full article (4 min)